ArticleACS chemical biology2019

A Novel Class of Common Docking Domain Inhibitors That Prevent ERK2 Activation and Substrate Phosphorylation.

Rachel M Sammons et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.